ProteinSimple Automates Aggregation Analysis
Published: Oct 25, 2011
SANTA CLARA, Calif., Oct. 25, 2011 /PRNewswire/ -- ProteinSimple today announced the launch of the Bot1 High Throughput Autosampler for its MFI 5000 Micro-Flow Imaging platforms. Bot1 automates analysis of protein aggregates and particles by Micro-Flow imaging. Bot1 will be unveiled at the IBC's 11th Annual Formulation Strategy for Protein Therapeutics conference, November 1-3, 2011, in Long Beach, CA.
Protein therapeutic manufacturers must monitor microscopic particles and protein aggregates due to concerns about safety and immunogenicity. ProteinSimple's MFI systems measure visible and sub-visible particles and protein aggregates with unmatched accuracy and reproducibility, and have been adopted by major pharmaceutical and biotechnology companies worldwide.
This new integrated MFI system represents the world's first automated platform designed specifically for particle and protein aggregate monitoring. Automated analysis improves data quality, reduces labor costs and increases sample throughput, ultimately accelerating the development of protein therapeutics formulations.
"Manual sample introduction for traditional particle counters is painfully tedious," commented Susan Darling, Director of Product Management. "MFI systems have been embraced by our customers for their ability to accurately characterize and quantify sub-visible particles. Bot1's automation further distinguishes MFI from our competitors. Formulation development scientists will realize new levels of speed, reproducibility and accuracy."
ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. The Company's strategy is to power protein research by making it simpler and more quantitative, ultimately revealing new insights into the true nature of proteins. ProteinSimple has built a unique portfolio of protein analysis tools including systems for traditional protein imaging, systems to probe the structure and purity of protein based therapeutics and systems that provide fresh insight into protein signaling. ProteinSimple has over 180 employees, more than 10,000 systems installed around the world and is headquartered in Santa Clara, California. For more information, visit www.proteinsimple.com.